|
Atomistry » Fluorine » PDB 5hu9-5ifd » 5ia5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 5hu9-5ifd » 5ia5 » |
Fluorine in PDB 5ia5: Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050)Enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050)
All present enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050):
2.7.10.1; Protein crystallography data
The structure of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050), PDB code: 5ia5
was solved by
D.Kudlinzki,
V.L.Linhard,
S.L.Gande,
S.Sreeramulu,
K.Saxena,
S.Heinzlmeir,
G.Medard,
B.Kuester,
H.Schwalbe,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050)
(pdb code 5ia5). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050), PDB code: 5ia5: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 5ia5Go back to![]() ![]()
Fluorine binding site 1 out
of 2 in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050)
![]() Mono view ![]() Stereo pair view
Fluorine binding site 2 out of 2 in 5ia5Go back to![]() ![]()
Fluorine binding site 2 out
of 2 in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Golvatinib (E7050)
![]() Mono view ![]() Stereo pair view
Reference:
S.Heinzlmeir,
D.Kudlinzki,
S.Sreeramulu,
S.Klaeger,
S.L.Gande,
V.Linhard,
M.Wilhelm,
H.Qiao,
D.Helm,
B.Ruprecht,
K.Saxena,
G.Medard,
H.Schwalbe,
B.Kuster.
Chemical Proteomics and Structural Biology Define EPHA2 Inhibition By Clinical Kinase Drugs. Acs Chem. Biol. V. 11 3400 2016.
Page generated: Tue Jul 15 04:07:45 2025
ISSN: ESSN 1554-8937 PubMed: 27768280 DOI: 10.1021/ACSCHEMBIO.6B00709 |
Last articlesF in 6DTXF in 6DMI F in 6DTW F in 6DRW F in 6DPY F in 6DMG F in 6DPR F in 6DNP F in 6DPQ F in 6DAT |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |